Walleye Trading
AMPH icon

Walleye Trading’s Amphastar Pharmaceuticals AMPH Stock Holding History

Walleye Trading’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-13,400
Closed -$194K – 4463
2017
Q1 		$194K Buy
+13,400
New +$211K ﹤0.01% 2967
2016
Q4 		– Sell
-8,800
Closed -$167K – 4674
2016
Q3 		$167K Buy
8,800
+8,500
+2,833% +$154K ﹤0.01% 2946
2016
Q2 		$5K Buy
+300
New +$4.23K ﹤0.01% 4985
2016
Q1 		– Sell
-7,500
Closed -$107K – 5283
2015
Q4 		$107K Buy
+7,500
New +$99.1K ﹤0.01% 3233

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Walleye Trading's AMPH Position: Q2 2017 in Review

Walleye Trading sold out of Amphastar Pharmaceuticals (AMPH) in Q2 2017, closing a stake of 13,400 shares — an estimated $194K sold.

Walleye Trading first reported a position in AMPH in Q4 2015 and held it in 4 quarters. The position peaked at $194K in Q1 2017. 108 funds tracked by Wall St. Rank hold AMPH as of Q2 2017.

  • Walleye Trading reported no remaining Amphastar Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
  • Walleye Trading sold 13,400 Amphastar Pharmaceuticals shares in Q2 2017, an estimated $194K.
  • Walleye Trading first reported a position in Amphastar Pharmaceuticals in Q4 2015 and held it in 4 quarters.
  • Walleye Trading's Amphastar Pharmaceuticals position peaked at $194K in Q1 2017.
  • 108 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2017.

Based on Walleye Trading's 13F filing for Q2 2017, filed 14 Aug 2017.